Received: 5 June 2017
Accepted: 14 January 2018
First Online: 18 January 2018
Ethics approval and consent to participate
: MediciniInsight was approved by the Royal Australian College of General Practitioners (RACGP) National Research and Evaluation Ethics Committee on 10 January 2013. The program considers three different consent to participate levels before data collection. First, the general practice owner is provided with a comprehensive Practice Kit that includes information for them to make an informed decision to participate in the program. Second, GPs are informed by the general practice owner about the practice’s participation in the program, and are given the opportunity to consent to receiving individual tailored reports. Finally, patients are made aware of the program through promotional material that is displayed within the waiting room of all participating practices, so they have the opportunity of verbally informing the practice about their choice not to participate. Verbal consent was obtained considering that MedicineInsight does not collect patients’ identifiable information such as name, date of birth and address, thus representing a low safety risk for the participants. Additionally, all MedicineInsight data requests are approved by an independent Data Governance Committee that includes GPs, Statisticians and consumer representatives. Finally, the Human Research Ethics Committee of the University of Adelaide exempted this study of an ethical review, as it used existing and non-identifiable data.
: Not applicable.
: There authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.